XML 46 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Collaborative Research, Development and License Agreements (Tables)
 12 Months Ended
Dec. 31, 2012
Astra Zeneca
  
Summary of Revenues Earned by Major Customer

The following table summarizes the revenues earned under our agreement with AstraZeneca (in thousands):

 

     Years ended December 31,  
     2012      2011      2010  

Initial payments

    $ 720       $ 120       $ 10,778   

Performance of research activities

      2,462         642         3,315   
  

 

 

     

 

 

     

 

 

  

Total

    $ 3,182       $ 762       $ 14,093   
  

 

 

     

 

 

     

 

 

  
National Institutes of Health
  
Summary of Revenues Earned by Major Customer

The following table summarizes the revenues earned under the various arrangements with the NIH and NIAID (in thousands):

 

     Years ended December 31,  
     2012      2011      2010  

NIAID contracts

    $ 3,571       $ 2,730       $ 3,197   

All other NIH contracts

      368         380         743   
  

 

 

     

 

 

     

 

 

  

Total grant revenue

    $ 3,939       $ 3,110       $ 3,940   
  

 

 

     

 

 

     

 

 

  
Agreement With Gsk
  
Summary of Revenues Earned by Major Customer

The following table summarizes the revenues earned under our agreement with GSK (in thousands):

 

     Years ended December 31,  
     2012      2011      2010  

Initial payment

    $ 1,428       $ 1,428       $ 1,428   

Milestone revenue

      —           15,000         —     
  

 

 

     

 

 

     

 

 

  

Total

    $ 1,428       $ 16,428       $ 1,428